Whole-brain metabolic pattern analysis in patients with anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis

Eur J Neurol. 2022 Aug;29(8):2376-2385. doi: 10.1111/ene.15384. Epub 2022 May 29.

Abstract

Background and purpose: Faciobrachial dystonic seizures (FBDS) and hyponatremia are the distinct clinical features of autoimmune encephalitis (AE) caused by antibodies against leucine-rich glioma-inactivated 1 (LGI1). The present study aims to explore the pathophysiological patterns and neural mechanisms underlying these symptoms.

Methods: We included 30 patients with anti-LGI1 AE and 30 controls from a retrospective observational cohort. Whole-brain metabolic pattern analysis was performed to assess the pathological network of anti-LGI1 AE, as well as the symptom networks associated with FBDS. Logistic regression was applied to explore independent predictors of FBDS. Finally, we used a multiple regression model to investigate the hyponatremia-associated brain network and its effect on serum sodium levels.

Results: The pathological network of anti-LGI1 AE involved hypermetabolism in the cerebellum, subcortical structures and Rolandic area, as well as hypometabolism in the medial prefrontal cortex. The symptom network of FBDS included hypometabolism in the cerebellum and Rolandic area (pFDR <0.05). Hypometabolism in the cerebellum was an independent predictor of FBDS (p < 0.001). Hyponatremia-associated network highlighted a negative effect on the caudate nucleus, frontal and temporal white matter. The metabolism of the hypothalamus was negatively associated with (Pearson's R = -0.180, p = 0.342), while not the independent predictor for serum sodium level (path c' = -7.238, 95% confidence interval = -30.947 to 16.472).

Conclusions: Our results provide insights into the whole-brain metabolic patterns of patients with anti-LGI1 AE, including the symptom network associated with FBDS and the hyponatremia-associated brain network. The findings help us to understand the neural mechanisms underlying anti-LGI1 AE and to evaluate the progress of this disease.

Keywords: IGL1; autoimmune encephalitis; faciobrachial dystonic seizures; hyponatremia; metabolic pattern.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autoantibodies / blood
  • Autoimmune Diseases* / complications
  • Autoimmune Diseases* / metabolism
  • Brain* / metabolism
  • Humans
  • Hyponatremia / etiology
  • Hyponatremia / metabolism
  • Intracellular Signaling Peptides and Proteins / immunology
  • Limbic Encephalitis* / complications
  • Limbic Encephalitis* / metabolism
  • Retrospective Studies
  • Seizures / etiology
  • Seizures / metabolism
  • Sodium / blood

Substances

  • Autoantibodies
  • Intracellular Signaling Peptides and Proteins
  • LGI1 protein, human
  • anti-leucine-rich glioma-inactivated 1 autoantibody
  • Sodium

Supplementary concepts

  • Autoimmune limbic encephalitis